AI憂鬱症診斷軟體 iLLUMEEG®
研發團隊 R&D Team
獨家技術 Our Technology
獨家技術 Our Technology
生輝智醫AI憂鬱症診斷軟體是由生輝智醫與台北榮民總醫院神經醫學部的權威醫師，李正達主任團隊專案開發，結合新一代AI人工智慧與腦波的創新診斷治療技術。
iLLUMEEG® was developed by BrightPath Medical Solutions in collaboration with Taipei Veterans General Hospital in Taiwan, led by the leading psychiatric expert Prof. Cheng-Ta Li, (M.D., Ph.D).
獨家技術 Our Technology
獨家技術 Our Technology
獨家技術 Our Technology
生輝智醫運用大數據與機器學習技術，結合台北榮總權威團隊建立的臨床黃金標準進行模型訓練，成功開發出新一代可協助判定憂鬱症嚴重程度、頑固性及預測失能風險的AI 憂鬱症診斷軟體，為臨床提供更客觀、精準的量化指標。
BrightPath Medical utilises advanced big data analytics and machine learning, trained on clinical gold standards established by leading experts at Taipei Veterans General Hospital. This innovation has enabled the development of a next-ge
生輝智醫運用大數據與機器學習技術，結合台北榮總權威團隊建立的臨床黃金標準進行模型訓練，成功開發出新一代可協助判定憂鬱症嚴重程度、頑固性及預測失能風險的AI 憂鬱症診斷軟體，為臨床提供更客觀、精準的量化指標。
BrightPath Medical utilises advanced big data analytics and machine learning, trained on clinical gold standards established by leading experts at Taipei Veterans General Hospital. This innovation has enabled the development of a next-generation AI depression diagnostic system that assesses depression severity, identifies treatment resistance, and predicts disability risk—delivering objective and precise quantitative insights to support clinical decision-making.